sitagliptin
Facts
16 properties- Instance of
- type of chemical entity
- Subclass of
- 7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)butyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine
- Has use
- medication
- Active ingredient in
- Januvia, Ristaben, Tesavel, Xelevia
- Canonical SMILES
- C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N
- Chemical formula
- C₁₆H₁₅F₆N₅O
- Defined daily dose
- 0.1 g
- Isomeric SMILES
- C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N
- LiverTox likelihood score
- LiverTox toxicity likelihood category D
- Mass
- 407.118 Da
- Medical condition treated
- maturity-onset diabetes of the young type 2, type-1 diabetes
- Physically interacts with
- Dipeptidyl peptidase 4
- Pregnancy category
- Australian pregnancy category B3, US pregnancy category B
- Stylized name
- SITagliptin
- Subject has role
- dipeptidyl peptidase-4 inhibitors
- World Health Organisation international non-proprietary name
- sitagliptin
- OpenAlex ID
- C2779284873, C2910260750
- ATC code
- A10BH01
- CAB ID
- 134851
- CAS Registry Number
- 486460-32-6
- ChEBI ID
- 40237
- ChEMBL ID
- CHEMBL1422
- ChemSpider ID
- 3571948
- DSSTOX compound identifier
- DTXCID30120063
- DSSTox substance ID
- DTXSID70197572
- DrugBank ID
- DB01261
- DrugCentral ID
- 2448
- EC number
- 690-730-1
Show all 41 identifiers +29
- ECHA Substance Infocard ID
- 100.217.948
- Encyclopædia Britannica Online ID
- topic/sitagliptin
- Freebase ID
- /m/0dk8qr
- Guide to Pharmacology Ligand ID
- 6286
- HSDB ID
- 7516
- Human Metabolome Database ID
- HMDB0015390
- InChIKey
- MFFMDFFZMYYVKS-SECBINFHSA-N
- KEGG ID
- D08516
- LiverTox ID
- Sitagliptin
- MassBank accession ID
- MSBNK-Athens_Univ-AU225701, MSBNK-Athens_Univ-AU225702, MSBNK-Athens_Univ-AU225703, MSBNK-Athens_Univ-AU225704, MSBNK-Athens_Univ-AU225705, MSBNK-Athens_Univ-AU225707, MSBNK-Athens_Univ-AU225708, MSBNK-Athens_Univ-AU225709, MSBNK-Athens_Univ-AU225710, MSBNK-Athens_Univ-AU225711, MSBNK-Athens_Univ-AU225731, MSBNK-Athens_Univ-AU225732
+18 more
MSBNK-Athens_Univ-AU225733, MSBNK-Athens_Univ-AU225734, MSBNK-Eawag-EA290301, MSBNK-Eawag-EA290302, MSBNK-Eawag-EA290303, MSBNK-Eawag-EA290304, MSBNK-Eawag-EA290305, MSBNK-Eawag-EA290306, MSBNK-Eawag-EA290307, MSBNK-Eawag-EA290308, MSBNK-Eawag-EA290309, MSBNK-Eawag-EA290310, MSBNK-Eawag-EA290311, MSBNK-Eawag-EA290312, MSBNK-Eawag-EA290313, MSBNK-Eawag-EA290314, MSBNK-UFZ-UA008401, MSBNK-UFZ-UA008402 - MeSH concept ID
- M0480815
- MeSH descriptor ID
- D000068900
- MeSH tree code
- D03.383.129.799.725, D03.383.679.875
- MedlinePlus drug identifier
- a606023
- Microsoft Academic ID (discontinued)
- 2779284873
- NDF-RT ID
- N0000176069
- PDB ligand ID
- 715
- Probes And Drugs ID
- PD003506
- PubChem CID
- 4369359
- Reaxys registry number
- 9962060
- RxNorm CUI
- 593411
- SPLASH
- splash10-052r-0690500000-c28779e719a0e517d106, splash10-0076-0930000000-1337dd7fb10ab92722b5, splash10-00dl-0900000000-91485eb0052ad2f3637a, splash10-00di-0900000000-7d92431093315efaed86, splash10-000i-0390000000-c8853d370b51f01b194b, splash10-0a4i-0000900000-2895dd4a879799635ae6, splash10-007c-0970100000-17431cd80097dff5c35f, splash10-00dl-0910000000-29041ebd42cb7f6026df, splash10-00di-0900000000-dc60c3b1e5f0ba0e5e23, splash10-0umi-0900000000-b1e1f886377c8d9b2a5d, splash10-004i-0900000000-d9e2b332d0ff3c6e283b, splash10-0a4i-0000900000-3403c0e74f19a7d0832a
- SureChEMBL ID
- 17783
- UMLS CUI
- C1565750
- UNII
- QFP0P1DV7Z
- UniChem compound ID
- 56079
- WikiProjectMed ID
- Sitagliptin
Belongs to 1
Has use 1
Medical condition treated 1
Physically interacts with 1
Subject has role 1
← Drug or therapy used for treatment 1
← Physically interacts with 1
0 sources
Summary
sitagliptin is a type of chemical entity[1]. sitagliptin is a type of 7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)butyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine[2].
Key Facts
- Physically interacts with: Dipeptidyl peptidase 4[3]
- Canonical SMILES: C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N[4]
- Chemical formula: C₁₆H₁₅F₆N₅O[5]
- Has use: medication[6]
- Isomeric SMILES: C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC@@HNC@@HN">[7]
- Mass: 407.118 dalton[8]
- Medical condition treated: maturity-onset diabetes of the young type 2[9], type-1 diabetes[10]
- World Health Organisation international non-proprietary name: sitagliptin[11]
- Subject has role: dipeptidyl peptidase-4 inhibitors[12]
- Pregnancy category: Australian pregnancy category B3[13], US pregnancy category B[14]
- Active ingredient in: Januvia[15], Ristaben[16], Tesavel[17], Xelevia[18]
- Defined daily dose: 0.1 g[19]